A. Krishnan

1.3k total citations
22 papers, 541 citations indexed

About

A. Krishnan is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, A. Krishnan has authored 22 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 13 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in A. Krishnan's work include Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). A. Krishnan is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). A. Krishnan collaborates with scholars based in United States, India and Australia. A. Krishnan's co-authors include Sagar Lonial, Hongliang Shi, Brad S. Kahl, Sunita D. Nasta, Michael J. Robertson, John P. Leonard, Richard I. Fisher, Steven H. Bernstein, Benjamin Djulbegović and Anthony Boral and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

A. Krishnan

21 papers receiving 529 citations

Peers

Countries citing papers authored by A. Krishnan

Since Specialization

Citations

This map shows the geographic impact of A. Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Krishnan more than expected).

Fields of papers citing papers by A. Krishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Krishnan. The network helps show where A. Krishnan may publish in the future.

Co-authorship network of co-authors of A. Krishnan

This figure shows the co-authorship network connecting the top 25 collaborators of A. Krishnan. A scholar is included among the top collaborators of A. Krishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Krishnan. A. Krishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accessing the behavior and awareness of veterinary professionals towards antimicrobials use and antimicrobial resistance in Indian district 2024 ·Frontiers in Veterinary Science ·(unknown), (unknown), A. Krishnan, Vijay Pal Singh	0
2	Understanding Knowledge and Attitude of Farmers towards Antibiotic Use and Antimicrobial Resistance in Jhunjhunu District, Rajasthan India 2023 ·Antibiotics ·(unknown), A. Krishnan, (unknown), Vijay Pal Singh	5
3	Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation 2013 ·Bone Marrow Transplantation ·César O. Freytes, David H. Vesole, (unknown), Xiaobo Zhong, Robert Peter Gale, RA Kyle, Donna Reece, J. N. Alastair Gibson, Harry C. Schouten, Phillip McCarthy, Sagar Lonial, A. Krishnan, Angela Dispenzieri, Parameswaran Hari	38
4	Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies 2012 ·Leukemia ·Ari M. Vanderwalde, (unknown), (unknown), Liton Francisco, Saro H. Armenian, (unknown), F. Lennie Wong, Leslie Popplewell, George Somlo, Anthony S. Stein, AP Nademanee, A. Krishnan, Neil Kogut, SJ Forman, Smita Bhatia	33
5	Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study 2010 ·Leukemia ·Shaji Kumar, Ian W. Flinn, Stephen J. Noga, Parameswaran Hari, Robert M. Rifkin, Natalie S. Callander, Manish Bhandari, Jeffrey L. Wolf, Cristina Gasparetto, A. Krishnan, (unknown), Jonathan Glass, Entezam Sahovic, Hongliang Shi, Iain J. Webb, Paul G. Richardson, S. Vincent Rajkumar	60
6	Tanespimycin plus bortezomib in patients with relapsed and refractory multiple myeloma: Final results of a phase I/II study 2009 ·Journal of Clinical Oncology ·Paul G. Richardson, Asher Chanan‐Khan, Sagar Lonial, A. Krishnan, (unknown), Melissa Alsina, Maher Albitar, David M. Berman, Stephen Kaplita, K C Anderson	16
7	Autologous stem cell transplant (ASCT) for AIDS-related lymphoma (ARL) 2009 ·Infectious Agents and Cancer ·A. Krishnan, John A. Zaia, Joseph Alvarnas, Neil Kogut, (unknown), Auayporn Nademanee, Joycelynne Palmer, (unknown), SJ Forman	5
8	Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study 2008 ·Annals of Oncology ·André Goy, Steven H. Bernstein, Brad S. Kahl, Benjamin Djulbegović, Michael J. Robertson, Sven de Vos, Elliot Epner, A. Krishnan, John P. Leonard, Sagar Lonial, Sunita D. Nasta, Owen A. O’Connor, Hongliang Shi, Anthony Boral, Richard I. Fisher	243
9	Tanespimycin (T) + bortezomib (BZ) in multiple myeloma (MM): Pharmacology, safety and activity in relapsed/refractory (rel/ref) patients (Pts) 2007 ·Journal of Clinical Oncology ·Paul G. Richardson, Asher Chanan‐Khan, Sagar Lonial, A. Krishnan, (unknown), G. Cropp, (unknown), Robert G. Johnson, Alison L. Hannah, Kenneth C. Anderson	8
10	Phase I/II Report from a Multicenter Trial of Perifosine (KRX-0401) + Bortezomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma Previously Treated with Bortezomib. 2007 ·Blood ·Paul G. Richardson, Andrzej Jakubowiak, J. Wolf, (unknown), Jeff Zonder, Sagar Lonial, A. Krishnan, John Densmore, Irene M. Ghobrial, (unknown), Tara Kendall, (unknown), (unknown), Teru Hideshima, Thierry Façon, Peter Sportelli, Lawrence B. Gardner, Rebecca Birch, I. Craig Henderson, Kenneth Anderson	14
11	Phase I trial of escalating doses of total marrow irradiation (TMI) with helical tomotherapy and peripheral blood progenitor cell rescue (PBPC) following high-dose melphalan and PBPC as part of tandem high-dose therapy (THDT) for patients with multiple myeloma (MM) 2007 ·Journal of Clinical Oncology ·Jeffrey Y.C. Wong, George Somlo, Ricardo Spielberger, Stephen J. Forman, (unknown), Timothy E. Schultheiss, Paul Frankel, A. Krishnan, Firoozeh Sahebi, PM Parker	1
12	Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma 2006 ·Bone Marrow Transplantation ·Firoozeh Sahebi, Ricardo Spielberger, Neil Kogut, Henry C. Fung, Peter Falk, Pablo Parker, A. Krishnan, R. Rodríguez, Ryotaro Nakamura, Auayporn Nademanee, Leslie Popplewell, Paul Frankel, Christopher Ruel, (unknown), (unknown), Stephen J. Forman, George Somlo	26
13	Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial. 2006 ·Blood ·Paul G. Richardson, Robert J. Soiffer, Joseph H. Antin, Zhezhen Jin, Joanne Kurtzberg, (unknown), Gideon Steinbach, Karen F. Murray, G. B. Vogelsang, (unknown), A. Krishnan, Nancy A. Kernan, David Avigan, TR Spitzer, D Warren, Carolyn Revta, Lan Wei, Massimo Iacobelli, GB McDonald, Eva C. Guinan	6
14	Phase II Trial of SCIO-469 as Monotherapy (M) or in Combination with Bortezomib (MB) in Relapsed Refractory Multiple Myeloma (MM). 2006 ·Blood ·David S. Siegel, A. Krishnan, Sagar Lonial, Gurkamal Chatta, Melissa Alsina, Sundar Jagannath, Paul G. Richardson, R.J. Hohl, John A. Lust, Jack W. Singer, George Carrum, Jan S. Moreb, (unknown), Bart Barlogie, Richard T. Maziarz, Kenneth C. Anderson, Jiunn-Chang Lin, Ann M. Lowe, (unknown), (unknown)	16
15	Clinical Outcomes of Patients with T Cell NHL Undergoing Allogeneic Stem Cell Transplant. 2006 ·Blood ·Jasmine Zain, Joycelynne Palmer, (unknown), Leslie Popplewell, (unknown), A. Krishnan, Ryotaro Nakamura, R. Rodríguez, Stephen J. Forman, Mark Kirschbaum	1
16	Impact of rituximab on outcome of autologous transplantation for mantle cell lymphoma 2006 ·Journal of Clinical Oncology ·Aung Naing, Joycelynne Palmer, (unknown), Neil Kogut, Leslie Popplewell, R. Rodríguez, A. Krishnan, (unknown), Stephen J. Forman, Auayporn Nademanee	2
17	The outcome of ZBEAM, a regimen combining 90Y ibritumomab tiuxetan with high dose chemotherapy in elderly patients with non-Hodgkin’s lymphoma (NHL) 2005 ·Journal of Clinical Oncology ·A. Krishnan, Auayporn Nademanee, Stephen J. Forman, Henry C. Fung, A. Molina, Dave Yamauchi, Ricardo Spielberger, Neil Kogut, Andrew Raubitschek	9
18	Phase 1 Clinical Trial of KOS-953 + Bortezomib (BZ) in Relapsed Refractory Multiple Myeloma (MM). 2005 ·Blood ·Asher Chanan‐Khan, Paul G. Richardson, Melissa Alsina, Michael P. Carroll, Sagar Lonial, A. Krishnan, Maher Albitar, Yiqing Zhou, Constantine S. Mitsiades, G. Cropp, Alison L. Hannah, Kenneth C. Anderson	15
19	Should HIV-positive patients with lymphoma be offered stem cell transplants? 2003 ·Bone Marrow Transplantation ·A. Krishnan, John A. Zaia, Stephen J. Forman	13
20	Hematologic Aspects of HIV/AIDS 2001 ·Hematology ·A Levine, David T. Scadden, John A. Zaia, A. Krishnan	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact